Spots Global Cancer Trial Database for Patient Reported Outcomes Registry in Patient With Cancer Cachexia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Patient Reported Outcomes Registry in Patient With Cancer Cachexia

Official Title: Tablet-based Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced NSCLC or Advanced Pancreatic Cancer With Focus on Cancer Cachexia

Study ID: NCT02983500

Conditions

Metastatic Pancreatic Cancer

NSCLC, Metastatic

Interventions

Study Description

Brief Summary: Evaluation of patient reported outcomes (PRO) with tumor cachexia in a real life setting.

Detailed Description: The PRO Xie project will recruit a representative cohort of patients with advanced lung or advanced pancreatic cancer with a high risk for the development of cancer cachexia. Patient Reported Outcomes (PRO) are assessed in a real life setting by a questionnaire consisting of 20 questions: QoL is measured by SF12, fatigue by FACIT-F and cachexia by FAACT questionnaires, respectively. These data will determine the potential need for anti-cachexia treatment in those patients, as well as the number of underweight patients, the evaluation of general QoL, fatigue and cachexia and the evaluation of malnutrition.